Open Access 10.09.2020 | COVID-19 | Letter
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial
Erschienen in: Trials | Ausgabe 1/2020